hero-line-left hero-line-top

Bringing precision medicine to more patients

Our life sciences partners are helping us answer tough questions about complex issues in cancer care



Roche and Syapse are collaborating on methods for measuring real-world outcomes, and are exploring additional areas of collaboration with the potential to bring precision medicine and improve care for more patients.


Amgen and Syapse are creating opportunities for physicians and researchers within the Syapse Network to gain access to analytics, real-world evidence-based insights, and collaborative research opportunities. Amgen will also work with Syapse to develop real-world evidence standards to support the acceleration of therapies to market.

In the news

Biden Cancer Initiative pairs up with IBM, Syapse to improve access to clinical trial information

6/4/19 - The Biden Cancer Initiative has announced that multiple healthcare organizations — including BreastCancerTrials.org, IBM Watson Health, Massive Bio and Syapse — are creating a shared platform called the Oncology Clinical Trial Information Commons, which will help cancer patients to know their clinical trial options.



Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…